- Home
- NDRA vs HSDT Comparison
NDRA vs HSDT Comparison
Compare NDRA & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDRA
- HSDT
- Stock Information
- Founded
- NDRA 2007
- HSDT N/A
- Country
- NDRA United States
- HSDT United States
- Employees
- NDRA N/A
- HSDT N/A
- Industry
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NDRA Health Care
- HSDT Health Care
- Exchange
- NDRA Nasdaq
- HSDT Nasdaq
- Market Cap
- NDRA 2.3M
- HSDT 2.5M
- IPO Year
- NDRA 2017
- HSDT N/A
- Fundamental
- Price
- NDRA $3.58
- HSDT $0.21
- Analyst Decision
- NDRA Strong Buy
- HSDT Hold
- Analyst Count
- NDRA 1
- HSDT 1
- Target Price
- NDRA $46.00
- HSDT N/A
- AVG Volume (30 Days)
- NDRA 32.0K
- HSDT 19.5M
- Earning Date
- NDRA 08-13-2025
- HSDT 08-11-2025
- Dividend Yield
- NDRA N/A
- HSDT N/A
- EPS Growth
- NDRA N/A
- HSDT N/A
- EPS
- NDRA N/A
- HSDT N/A
- Revenue
- NDRA N/A
- HSDT $434,000.00
- Revenue This Year
- NDRA N/A
- HSDT N/A
- Revenue Next Year
- NDRA N/A
- HSDT $75.13
- P/E Ratio
- NDRA N/A
- HSDT N/A
- Revenue Growth
- NDRA N/A
- HSDT N/A
- 52 Week Low
- NDRA $2.90
- HSDT $0.20
- 52 Week High
- NDRA $197.75
- HSDT $24.00
- Technical
- Relative Strength Index (RSI)
- NDRA 51.99
- HSDT 20.97
- Support Level
- NDRA $3.14
- HSDT $0.30
- Resistance Level
- NDRA $3.60
- HSDT $0.38
- Average True Range (ATR)
- NDRA 0.20
- HSDT 0.13
- MACD
- NDRA 0.05
- HSDT 0.04
- Stochastic Oscillator
- NDRA 72.13
- HSDT 0.46
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS) is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.